NEW YORK (GenomeWeb) – Nuclea Biotechnologies said today that it is partnering with the Institut de recherches cliniques de Montréal (IRCM) to validate mass spec assays for insulin, proinsulin, and c-peptide.

Under the partnership the two companies will run the assays on clinical sample cohorts at both Nuclea and IRCM's facilities to test the precision, sensitivity, and reproducibility of the assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Popular Mechanics reports that Caltech researchers have built a prototype nanobot using DNA.

The Sacramento Bee writes that direct-to-consumer genetic testing connected a woman to sperm donor-conceived half siblings.

In PLOS this week: gene expression catalog for sheep, viral diversity among respiratory samples from camels, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.